drugset / Trial / NCT00279565
Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized, single-center, controlled study is designed to evaluate the safety, tolerability, and efficacy of treatment with Peg-Intron with Rebetol in methadone or buprenorphine maintenance patients with hepatitis C.
Timeline
- Start
- 2005-08
- Primary completion
- 2007-02
- Completion
- 2007-02
Outcome
Outcome not reported
Stopped: “The trial was terminated because of deviations from the protocol.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |
| Subject | Methadone | Other / unclassified | — | — |
| Subject | Pegylated interferon alfa-2b | Protein / enzyme biologic | — | — |
| Subject | Ribavirin | Small molecule | — | — |